Conditional approval for Spikevax vaccine for 12-year-olds and above

Conditional approval for Spikevax vaccine for 12-year-olds and above

Conditional approval for Spikevax vaccine for 12-year-olds and above
The Spikevax brand COVID-19 vaccine produced by Rovi Pharma Industrial Services in Spain has been given conditional approval for use in Malaysia by 12-year-olds and above.

Scroll to Top